grey market peptides retatrutide review Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide and the Grey Market:

How effective is retatrutide for weight loss in menopause

Unknown Pharmacokinetics We dont fully understand how these medications behave in the body at micro-doses, including their absorption, distribution, and elimination patterns

First, receptor selectivity profoundly influences biological outcomes the progression from mono- to dual- to triple-agonism demonstrates that multi-target peptides can achieve effects unattainable by single-target compounds

Activation of glucagon-like peptide-1 receptor inhibits growth and promotes apoptosis of human pancreatic cancer cells in a cAMP-dependent manner

Doing so carries significant safety risks, including exposure to counterfeit or unregulated substances, unknown drug interactions, and the absence of appropriate medical supervision

PMID: 40607156 bioRxiv2026 Jun 19